Cargando…
Should metformin remain the first-line therapy for treatment of type 2 diabetes?
Metformin is a biguanide that is used as first-line treatment of type 2 diabetes mellitus and is effective as monotherapy and in combination with other glucose-lowering medications. It is generally well-tolerated with minimal side effects and is affordable. Although the safety and efficacy of metfor...
Autores principales: | Baker, Chelsea, Retzik-Stahr, Cimmaron, Singh, Vatsala, Plomondon, Renee, Anderson, Victoria, Rasouli, Neda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809522/ https://www.ncbi.nlm.nih.gov/pubmed/33489086 http://dx.doi.org/10.1177/2042018820980225 |
Ejemplares similares
-
Design and rationale for the SIB trial: a randomized parallel comparison of semaglutide versus placebo on intestinal barrier function in type 2 diabetes mellitus
por: Rella, Steven, et al.
Publicado: (2023) -
A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications
por: Behzad, Molavi, et al.
Publicado: (2007) -
Euglycemic Diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 Canagliflozin
por: Kelmenson, Daniel A., et al.
Publicado: (2017) -
Should Remaining Stockpiles of Smallpox Virus (Variola) Be Destroyed?
por: Weinstein, Raymond S.
Publicado: (2011) -
Why Delusional Infestation should remain Delusional Infestation
por: Lepping, Peter, et al.
Publicado: (2020)